Dr. Thanarajasingam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2012 - 2016
Brigham and Women's HospitalResidency, Internal Medicine, 2008 - 2011- Mayo Clinic College of MedicineClass of 2008
Certifications & Licensure
MN State Medical License 2012 - 2025
MA State Medical License 2010 - 2013- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Comparison of Survivorship Care Guidelines for Patients With Lymphoma: Recommendations for Harmonization and Future Research Agenda.Bryan Valcarcel, Kerry J Savage, Brian K Link, John P Leonard, Kara M Kelly
JCO Oncology Practice. 2024-12-06 - 1 citationsIdentification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse e...Minji K Lee, Sandra A Mitchell, Ethan Basch, Gina L Mazza, Blake T Langlais
Quality of Life Research. 2024-11-06 - Statistical properties of items and summary scores from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a di...Carolyn Mead-Harvey, Ethan Basch, Lauren J Rogak, Blake T Langlais, Gita Thanarajasingam
Clinical Trials. 2024-10-23
Abstracts/Posters
- A Phase II Study of Nivolumab in Patients with Relapsed or Refractory Peripheral T-Cell LymphomaGita Thanarajasingam, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Patient Experience of Chimeric Antigen Receptor (CAR)-T Cell Therapy Vs. Stem Cell Transplant: Longitudinal Patient Reported Adverse Events, Cognition and Quality of LifeGita Thanarajasingam, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Treatment and Lifestyle Risk Factors for Cardiovascular Disease Post Lymphoma Diagnosis: A Prospective Study in the Modern Treatment EraGita Thanarajasingam, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
First Walk on! In Memory of Chuck Papanos Is Set for July 30July 6th, 2021- Predictors of Short-Term Survival in Waldenström MacroglobulinemiaJuly 14th, 2020
Novel Metric Sheds Light on When Adverse Events May OccurJune 6th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
